Aspen Pharmacare Holdings Limited

Aspen Pharmacare expects to be ready to launch at market formation for its proposed semaglutide generics after achieving “confidence now in both the quality and acceptability of [our] dossiers,” havin

With the addition of weight loss and obesity indications and more patient-friendly dosing regimens beginning at the start of the current decade, glucagon-like-peptide-1 (GLP-1) receptor agonists have

South Africa’s Aspen Pharmacare is the latest to throw its weight behind looming off-patent GLP-1 opportunities, disclosing that it has secured a commercial license from an undisclosed company for t

South Africa’s Aspen Pharmacare believes it has taken a “major step in our stated strategic objective of increasing our presence in China,” after striking a deal to acquire Sandoz’s business in Chin